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Intraoperative angiography in cerebrovascular neurosurgery can drive the repositioning or addition of
aneurysm clips. Our institution has switched from a strategy of intraoperative digital subtraction
angiography (DSA) universally, to a strategy of indocyanine green (ICG) videoangiography with DSA on
an as-needed basis. We retrospectively evaluated whether the rates of perioperative stroke, unexpected
postoperative aneurysm residual, or parent vessel stenosis differed in 100 patients from each era (2002,
‘‘DSA era’’; 2007, ‘‘ICG era’’). The clip repositioning rate for neck residual or parent vessel stenosis did not
differ signiﬁcantly between the two eras. There were no differences in the rate of perioperative stroke or
rate of false-negative studies. The per-patient cost of intraoperative imaging within the DSA era was
signiﬁcantly higher than in the ICG era. The replacement of routine intraoperative DSA with ICG video-
angiography and selective intraoperative DSA in cerebrovascular aneurysm surgery is safe and effective.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Residual aneurysm ﬁlling, parent vessel stenosis, and perforat-
ing artery compromise have complicated open clipping of aneu-
rysms since the origin of cerebrovascular neurosurgery. In the
last decade, our institution and others have advocated the routine
or selective use of intraoperative digital subtraction angiography
(DSA) to assess aneurysm residual and vessel patency [1–7]. Some
neurosurgeons have advocated selective intraoperative DSA use,
such as in large or complex aneurysms only, and cited that routine
DSA is not necessarily cost-effective [4]. However, our group has
previously published a study of routine DSA in all aneurysm clip
patients, and found that surgeons could not always predict preop-
eratively when intraoperative DSA would be useful, suggesting
more routine use [5].
Indocyanine green (ICG) is a near-infrared (NIR) ﬂuorescent
compound utilized since the 1950s in humans for liver diagnostics
and subsequently approved by the US Food and Drug Administra-
tion for ophthalmologic angiography in the 1970s. ICG is excreted
unchanged via the hepatic system and the incidence of major or
minor complications associated with systemic exposure is mini-
mal. The dye is injected intravenously, is quickly plasma-proteinbound, and reaches the cerebral vasculature within 30 seconds.
The ﬁrst report of indocyanine green angiography (ICGA) in
cerebrovascular surgery utilized a separate NIR light source and
NIR-sensitive video camera, but soon afterwards the technology
for both the NIR light source and recording was integrated into
the surgical microscope [8,9]. This allows for the real-time
visualization of vessel ﬂow and aneurysm ﬁlling within the surgi-
cal ﬁeld in both arterial and venous phases. In the last decade, our
group and others have successfully utilized ICGA in surgery for
elective and ruptured cerebral aneurysms, intracranial–extracranial
bypass, and cerebral arteriovenous malformations [9–24]. ICGA has
similar rates of clip repositioning and parent vessel stenosis when
compared head-to-head with either intraoperative or postoperative
DSA [9,23,25]. Published studies have focused on the technical
sensitivity and speciﬁcity of ICGA when compared to a ‘‘gold
standard’’ of intraoperative or postoperative DSA in patients receiving
both imaging modalities. This literature has established ICGA as a
viable alternative to intraoperative DSA, but these studies are
focused on technical comparisons of the imaging modalities.
However, no study to our knowledge has compared patient
outcomes following the replacement of intraoperative DSA with
routine ICGA in a clinical practice. While ICG is a more rapid and
convenient form of angiography in clinical practice, its value would
be much less if its use was not associated with similar or better
outcomes. Our institution now routinely employs ICGA during
Table 1
Patient demographics
DSA era ICG era
Patients 100 100
Treated aneurysms 119 122
Mean age, years 52.2 54.0
Sex, M:F 26:74 34:66
Presentation
Elective 46* 64*
Acute SAH 49* 30*
Remote SAH 5 6
Location, n (%)
Anterior circulation 97 (82%) 108 (89%)
ACoA 19 (16%) 30 (25%)
ACA 9 (8%) 2 (2%)
ICA 24 (20%) 20 (16%)
MCA 13 (11%)* 36 (30%)*
OphthA 10 (8%) 16 (13%)
PCoA 22 (18%)* 4 (3%)*
Posterior circulation 22 (18%) 14 (11%)
AICA 3 (3%) 0 (0%)
BasilarA 8 (7%) 6 (5%)
PCA 2 (2%) 0 (0%)
PICA 7 (6%) 5 (4%)
SCA 2 (2%) 3 (2%)
Intraop DSA 81%* 13%*
Intraop ICG 0%* 79%*
Periop stroke 4% 3%
Clip repositioning 6% 4%
False-neg rate 1% 1%
Routine postop DSA 12% 8%
ACA = anterior cerebral artery, ACoA = anterior communicating artery,
AICA = anterior inferior cerebellar artery, BasilarA = basilar artery, DSA = digital
subtraction angiography, F = female, False-neg = false-negative study, ICA = internal
carotid artery, ICG = indocyanine green, Intraop = intraoperative, M = male, MCA =
middle cerebral artery, OphthA = ophthalmic artery, PCA = posterior cerebral artery,
PCoA = posterior communicating artery, Periop = perioperative (within 72 hrs),
PICA = posterior inferior cerebellar artery, postop = postoperative, SAH = subarach-
noid hemorrhage, SCA = superior cerebellar artery.
* p < 0.05 comparing DSA era to ICG era.
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micro-Doppler techniques; this practice evolved over the era of the
Barrow Ruptured Aneurysm Trial (BRAT) [26,27]. Our clinical experi-
ence represents a natural comparison of the two diagnostic methods
via retrospective review of two ‘‘eras’’: the year prior to BRAT (2002),
in which the intent was for all aneurysm clipping patients to receive
intraoperative DSA, and the year after BRAT (2007), in which the pri-
mary intraoperative angiographic modality for aneurysm clipping pa-
tients was to receive ICGA. We assembled the present study not to
compare the previously published intraoperative utility of ICGA ver-
sus intraoperative DSA, but rather to assess if a paradigm shift away
from routine intraoperative DSA to routine ICGA with selective intra-
operative DSA would result in similar patient outcomes, such as
stroke and return to the operating room for unexpected postoperative
imaging ﬁndings.
2. Methods
2.1. Study population
We retrospectively identiﬁed all aneurysms treated via open
microsurgical clipping in the years 2002 (‘‘DSA era’’) and 2007
(‘‘ICG era’’) at the Barrow Neurological Institute, AZ, USA using a
departmental registry. The ﬁrst 100 patients in each year with
available inpatient and outpatient records were identiﬁed and ana-
lyzed. This study was approved by the St. Joseph’s Hospital and
Medical Center Institutional Review Board for human research.
2.2. Data collection
Hospital and clinical records were reviewed, as were pre and
postoperative imaging studies. Each patient was treated by an
experienced cerebrovascular neurosurgeon (R.F.S., P.N., or J.M.Z.).
Intraoperative DSA was performed by an endovascular neurosur-
geon or a diagnostic neuroradiologist. Patient characteristics iden-
tiﬁed included age at surgery, sex, aneurysm size and location, the
form of intraoperative imaging used, and pre and postoperative
neurological deﬁcits. Each patient was assessed for perioperative
stroke, deﬁned here as a new permanent or transient neurological
deﬁcit within 72 hours of surgery with an appropriate imaging cor-
relate on MRI or CT scan. Technical difﬁculties with either imaging
modality were noted, as were residual aneurysm ﬁlling and parent
vessel occlusion on independent postoperative imaging such as
follow-up DSA, computed tomography angiography (CTA), or mag-
netic resonance angiography (MRA).
2.3. Statistical analysis
Univariate analysis to compare categorical variables was per-
formed using Fisher’s exact test with a probability value of <0.05
considered statistically signiﬁcant. Univariate analysis to compare
continuous variables was performed using Student’s t-test with a
probability value of <0.05 considered statistically signiﬁcant. All
analyses were conducted using GraphPad QuickCalcs (GraphPad
Software Inc., La Jolla, CA, USA).
3. Results
3.1. Patient demographics
We identiﬁed the ﬁrst 100 consecutive patients undergoing 100
craniotomies for the treatment of 119 aneurysms in the year 2002
(‘‘DSA era,’’ Table 1), and the ﬁrst 100 consecutive patients
undergoing 100 craniotomies for the treatment of 122 aneurysms
in the year 2007 (‘‘ICG era,’’ Table 1). The average age betweenpatients in each era did not differ signiﬁcantly (52.2 years in DSA
era, 54.0 years in ICG era, p = not signiﬁcant [NS]). A female
predominance was seen in both study periods. More patients pre-
sented with aneurysm rupture and subarachnoid hemorrhage
(aSAH) in the DSA era than in the ICG era (49% versus 30%,
p = 0.008, Fisher’s exact test). Furthermore, more middle cerebral
artery (MCA) aneurysms and fewer posterior communicating
artery (PCoA) aneurysms were treated in the ICG era than DSA
era (30% versus 11% and 3% versus 18%, respectively, p < 0.05, Fish-
er’s exact test). Regardless of the modality used intraoperatively,
all patients at our institution underwent CTA, MRA, and/or DSA
postoperatively within 24 hours of surgery as a control.3.2. Utilization of intraoperative modalities
In the DSA era, 81% of patients underwent intraoperative DSA;
none underwent ICGA as it had not yet been introduced at our insti-
tution. In the ICG era, 79% of patients underwent ICGA, and 13% of
patients underwent intraoperative DSA either in conjunction with
(2%) or as a substitution of (11%) ICG. Patients who underwent
intraoperative DSA within the ICG era did not differ from patients
who underwent ICGA alone in any variable examined (Table 2). In
one patient treated with ICGA, the parent vessel could not be
adequately visualized and so intraoperative DSA was utilized.
Otherwise, there were no cases of intraoperative technical failure
using either technique. No patient suffered an allergic reaction to
either injected iodinated contrast or ICG. No pseudoaneurysms or
Table 2
Comparison of patients within ICG era
ICG only DSA only or DSA + ICG
Patients 78 13
Treated aneurysms 94 16
Mean age, years 55.6 52.6
Acute SAH 30 (38%) 3 (23%)
Location, n (%)
Anterior circulation 83 (88%) 16 (100%)
ACoA 23 (24%) 5 (31%)
ACA 2 (2%) 0 (0%)
ICA 15 (16%) 2 (12.5%)
MCA 28 (30%) 7 (44%)
OphthA 1 (1%) 1 (6%)
PCoA 14 (15%) 1 (6%)
Posterior circulation 11 (12%) 0 (0%)
AICA 0 (0%) 0 (0%)
BasilarA 4 (4%) 0 (0%)
PCA 0 (0%) 0 (0%)
PICA 5 (5%) 0 (0%)
SCA 2 (2%) 0 (0%)
Periop stroke, n (%) 3 (4%) 0 (0%)
Clip repositioning, n (%) 3 (4%) 1 (8%)
ACA = anterior cerebral artery, ACoA = anterior communicating artery, AICA =
anterior inferior cerebellar artery, BasilarA = basilar artery, DSA = digital subtraction
angiography, F = female, ICA = internal carotid artery, ICG = indocyanine green, M =
male, MCA = middle cerebral artery, OphthA = ophthalmic artery, PCA = posterior
cerebral artery, PCoA = posterior communicating artery, Periop = perioperative
(within 72 hours), PICA = posterior inferior cerebellar artery, SAH = subarachnoid
hemorrhage, SCA = superior cerebellar artery.
Fig. 1. (A) Computed tomography angiography three-dimensional reconstruction demon
subarachnoid hemorrhage with a right Sylvian ﬁssure clot seen on axial CT scan. Used w
Fig. 2. During surgery, the smaller superior branch (A, arrow) showed good ﬁlling dista
visualized. Used with permission from Barrow Neurological Institute.
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intraoperative DSA in either era.
3.3. Clinical utility and stroke outcomes
Both modalities altered surgical practice in the form of
providing information that led to the repositioning or addition of
aneurysm clips due to ﬁndings of aneurysm ﬁlling or parent vessel
stenosis in select patients. In the DSA era, intraoperative angiogra-
phy demonstrated residual aneurysm ﬁlling in four patients and
vessel stenosis in two patients for a total of six clip adjustments
(6%). In the ICG era, two patients demonstrated intraoperative
residual aneurysm ﬁlling requiring clip repositioning or additional
clips, and two patients had vessel stenosis for a total repositioning
rate of 4% (p = NS when compared to DSA era). Of these four
patients, one required both DSA and ICGA to properly assess distal
vessel stenosis in a complex anterior communicating artery
(ACoA); the other three patients underwent ICGA only prior to clip
revision.
One patient in the DSA era undergoing elective basilar tip
aneurysm clipping, who received intraoperative DSA, had a small
unexpected area of aneurysm ﬁlling as seen on postoperative
DSA after the patient suffered aSAH on postoperative day 2
(false-negative rate, 1%). This was managed conservatively, and fol-
low-up angiography demonstrated total aneurysm obliteration.
One patient in the ICG era undergoing elective MCA bifurcation
aneurysm clipping, who received ICGA only, had unexpected
parent vessel stenosis as observed on postoperative day 3 DSAstrates a right middle cerebral artery aneurysm responsible for (B) a Fisher grade III
ith permission from Barrow Neurological Institute.
lly on indocyanine green videoangiography (B, arrow) but could not be completely
Fig. 3. (A) Postoperative anteroposterior and (B) lateral right internal carotid artery
angiography demonstrated severe stenosis of the smaller branch (arrows). The
patient subsequently developed a left pronator drift and axial CT perfusion scan (C)
showed cerebral hypoperfusion on the right. Used with permission from Barrow
Neurological Institute.
Fig. 4. Intraoperative anteroposterior angiogram after the clip was revised at a
second craniotomy shows no residual stenosis. The patient did well clinically and
made a modiﬁed Rankin Scale score 1 recovery. Used with permission from Barrow
Neurological Institute.
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room for clip repositioning, with no neurological sequeleae
(Fig. 1–4).
In the DSA era, perioperative strokes occurred in four patients
(4%, Table 2). These patients suffered an ipsilateral caudate headinfarct after internal carotid artery aneurysm clipping with tran-
sient dysarthria (Patient 1), an ipsilateral MCA–posterior cerebral
artery watershed infarct after ophthalmic artery aneurysm clip-
ping with no signiﬁcant sequelae (Patient 2), a cerebellar posterior
inferior cerebellar artery (PICA) infarct due to intraoperative vessel
avulsion and sacriﬁce during PICA aneurysm clipping with postop-
erative respiratory failure requiring tracheostomy (Patient 3), and
a cerebellar PICA infarct due to proximal vessel stenosis after PICA
aneurysm clipping with no signiﬁcant sequelae (Patient 4). All pa-
tients except Patient 3 received intraoperative DSA and Patient 4
had intraoperative clip repositioning but persistent vessel stenosis.
In the ICG era, there were three (3%) perioperative strokes (Table 3).
These included a brainstem perforator infarct after basilar artery
aneurysm clipping with a permanent hemiparesis (Patient 5), an
ipsilateral internal capsule infarct after MCA aneurysm clipping
with transient hemiparesis (Patient 6), and an ipsilateral internal
capsule infarct after clipping of ACoA and PCoA aneurysms with
transient hemiparesis (Patient 7). All three ICG era patients re-
ceived ICGA, and Patient 6 had intraoperative clip repositioning.
There was no statistically signiﬁcant difference in the incidence
of perioperative stroke between the DSA and ICG era patients
(p = NS). There was no reduction in the utilization of immediate
postoperative DSA (within 24 hours of surgery) in the routine
intraoperative DSA era when compared to the ICG era (12% versus
8%, respectively, p = NS).
3.4. Cost
Both intraoperative DSA and ICGA have signiﬁcant buy-in cost
related to equipment purchases, such as ﬂuoroscopy machines,
technicians, and/or NIR equipped surgical microscopes. These costs
vary widely between institutions based on established equipment,
and we did not seek to quantify these initial costs.
We analyzed two factors in relation to the cost of each intraop-
erative imaging modality. First was the length of time required for
acquiring images; at our institution, an ICGA ‘‘run’’ takes under
3 minutes, while intraoperative DSA takes approximately 15 to
20 minutes. This translates to an additional cost at our institution,
based on billing per 15 minutes of operating room time, of
$USD2290 for DSA. Secondly, we analyzed the patient charge for
the procedure itself. At our institution, ICGA carries no additional
patient charge beyond the minor cost of the intravenous dye itself.
Table 3
Details of perioperative strokes by era
Patient Age, years Aneurysm location(s) SAH/Elective Event Sequelae Modality used Intraop clip reposition?
DSA era
1 47 ICA ( 3) Elective Caudate infarct Transient dysarthria DSA No
2 41 OphthA Elective MCA/PCA watershed infarct None DSA No
3 68 PICA SAH Cerebellar infarct Tracheostomy None No
4 48 PICA SAH Cerebellar infarct None DSA Yes
ICG era
5 50 BasilarA Elective Perforator infarct Hemiparesis ICG No
6 65 MCA Elective Internal capsule infarct Transient hemiparesis ICG Yes
7 56 ACoA, PCoA SAH Internal capsule infarct Transient hemiparesis ICG No
ACoA = anterior communicating artery, BasilarA = basilar artery, DSA = digital subtraction angiography, ICA = internal carotid artery, ICG = indocyanine green, Intra-
op = intraoperative, MCA = middle cerebral artery, OphthA = ophthalmic artery, PCA = posterior cerebral artery, PCoA = posterior communicating artery, PICA = posterior
inferior cerebellar artery, SAH = subarachnoid hemorrhage.
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patients at a cost of $USD14,522 for a single carotid or vertebral ar-
tery injection, as well as the relatively minor cost of disposable
equipment. In the DSA era (81% DSA utilization), these two charges
lead to an average cost of intraoperative angiography of
$USD13,617 per patient. In comparison, using the same charges,
the cost per patient of intraoperative angiography in the ICG era
(13% DSA utilization) was $USD2186.4. Discussion
ICGA has over the last decade become an established method of
assessing intraluminal ﬂow in cerebrovascular neurosurgery. Com-
pared to intraoperative DSA, advantages of ICGA include the speed
of image acquisition, the ability to manipulate the surgical ﬁeld
during the ICG study, and improved resolution to assess even small
perforating arteries. This is the ﬁrst study to our knowledge com-
paring the safety and efﬁcacy of a clinical practice transition to
routine ICGA compared to an era of routine intraoperative DSA.
Both modalities had a utilization rate of approximately 80% within
their respective eras. The rates of detecting residual aneurysm
dome ﬁlling or parent vessel stenosis intraoperatively were simi-
lar: no statistically signiﬁcant differences were observed between
the ICGA and intraoperative DSA eras, although event rates were
low in both eras. Both modality eras had one false-negative study
each: an unexpected aneurysm remnant in the DSA era and an
unexpected parent vessel stenosis in the ICG era. The incidence
of perioperative stroke also did not differ between eras (3% for
ICG and 4% for intraoperative DSA) and these values are within
the range reported in other large surgical series [13,4]. Lastly, the
routine use of ICGA compared to routine DSA led to a per-patient
cost reduction of $USD11,431 based on billing for operating room
time and catheter angiography itself. However, service charges
can vary widely per institution and so this cost reduction may
not be generalizable, especially outside the USA. Furthermore,
the acquisition cost of ICG-enabled surgical microscopes was not
included in our analysis and also will vary widely based on
institution. A single stroke, or return to the operating room for
repositioning, would drastically alter any cost analysis and we
did not attempt to analyze this further.
Our study is limited by its retrospective nature and we
acknowledge the inherent pitfalls of any such analysis. Multiple
factors not analyzed may differ between the eras, such as
additional operating room technological advances, the surgeons
performing clipping, and individual surgeon experience. Addition-
ally it is possible that clips were more often repositioned due to
vessel stenosis or residual aneurysm ﬁlling than we have reported,
but that some of these events were not recorded within the oper-
ative report. Nonetheless, the purpose of this study was to assess
the overall outcomes achieved with each era, and not to comparespeciﬁc intraoperative utility between modalities. We attempted
to minimize the number of strokes that were actually due to cere-
bral vasospasm by only including deﬁcits suffered within 72 hours
of surgery. However, some patients with subarachnoid hemor-
rhage will present with vasospasm immediately postoperatively,
and therefore the strokes reported here may include events not di-
rectly related to surgical compromise. Lastly, some patients (13%)
underwent intraoperative DSA within the ICG era. Thus, a selection
bias whereby simpler aneurysms were examined using ICGA alone,
and more complex aneurysms examined with DSA, cannot be
excluded. However, no clinical variable that we studied differed
between patients in the ICG era who underwent ICGA alone or
those who underwent DSA as well as or without ICGA including
aneurysm location, acute subarachnoid hemorrhage presentation,
and number of aneurysms clipped per patient was signiﬁcant. Fur-
thermore, ours was a ‘‘real-world’’ retrospective study examining
the clinical safety of routine ICGA use compared to routine DSA
use. Therefore, the selective use of intraoperative DSA when
needed as determined by the surgeon within the ICG era does
not invalidate our overall conclusion that ICGA is a safe ﬁrst-line
intraoperative modality; we do not mean to suggest that ICGA
can replace DSA in all cases.
High-quality intraoperative DSA still has an important role in
aneurysm surgery, despite a transition to routine ICGA.
Technically, ICGA is limited by the ﬁeld of view of the operative
microscope, and at times this precludes its use to assess all rele-
vant vessels if obscured by the aneurysm or clip. Similarly, patients
with highly calciﬁed vessels or complex, partially thrombosed
aneurysms may still be better suited for intraoperative DSA.
However, intraoperative DSA remains itself an imperfect modality
with up to a reported 5–8% rate of unexpected vessel stenosis or
aneurysm ﬁlling compared to the ‘‘gold standard’’ of postoperative
DSA [28]. Our experience is that postoperative imaging, either CTA
or DSA, is required to fully assess the vasculature even after intra-
operative DSA. As such, we found that the use of intraoperative
DSA does not spare the patient additional postoperative imaging
compared to ICGA. At our institution patients routinely undergo
postoperative CTA or MRA with selective use of postoperative
DSA, regardless of the utilized intraoperative modality. A
combination of ICGA, intraoperative DSA, and/or micro-Doppler
ultrasonography, postoperative vascular imaging, and the personal
experience of a subspecialty-trained cerebrovascular neurosurgeon
may be required for the most challenging aneurysms to avoid
complications due to missed ﬁndings, and therefore to achieve
the best possible patient outcomes.5. Conclusions
An era utilizing routine ICGA with selective use of intraopera-
tive DSA produced equally low rates of unexpected aneurysm
1382 D.A. Hardesty et al. / Journal of Clinical Neuroscience 21 (2014) 1377–1382ﬁlling, parent vessel compromise, and perioperative strokes when
compared to an era utilizing routine intraoperative DSA. Intraoper-
ative ICGA is a safe, effective, and cost-effective replacement to
routine intraoperative diagnostic angiography. However, a role
for postoperative imaging remains as no intraoperative modality
can be considered as yet a gold standard.
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